Every Tuesday morning we deliver healthcare M&A news, deals on the market, and valuation insights.
Sep 1, 2026
•
11 min read
Radiology Partners pays 5x revenue for Everlight because radiologists are scarce, McKesson buys an oncology tollbooth for $2.25B, and Sword's Headspace deal surfaces through a state filing at a tenth of its 2021 valuation.
Aug 25, 2026
9 min read
Francisco Partners bets on continued margin expansion at Weave, Perceptive Advisors runs the Hicuity deal from the lender's seat, and this week's occ med and pharma-consulting listings both find live comps in the announced deals column.
Aug 18, 2026
10 min read
Varex goes private at a 50% premium that is still lower than every disclosed imaging equipment deal since 2012, two dermatology platforms merge because nobody can exit, and CHG buys a four-year-old CRNA staffing firm for its 84% clinician retention.
Aug 11, 2026
13 min read
KKR pays 14.6x for Integer's capability arbitrage, VitalConnect exits at 4.4x revenue or roughly the money it raised, and Fresenius sells two dialysis centers into a nephrologist JV at 2-3x EBITDA.
Aug 4, 2026
Advantage Behavioral sells for ~7x ($550.9m) to a NFP and the low multiple likely lies in the management fee structure, MiMedx buys a mix repair at a 46% premium, and a broker listed CRO in a fast growing market with $57m revenue.
Jul 28, 2026
Intermountain buys out Surgery Partners in Idaho Falls at 9.5x, Cardinal grabs AdaptHealth's diabetes falling knife, and the DMEPOS 36-month rule quietly breaks one of this week's listings.
